Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(4):608–616. doi: 10.1111/j.1750-3639.2003.tb00489.x

Human Monoclonal IgM Antibody Promotes CNS Myelin Repair Independent of Fc Function

Bogoljub Ciric 1, Charles L Howe 2, Mateo Paz Soldan 2, Arthur E Warrington 2, Allan J Bieber 2,3, Virginia Van Keulen 1, Moses Rodriguez 1,2,3, Larry R Pease 1,✉
PMCID: PMC8096021  PMID: 14655764

Abstract

The human monoclonal IgM antibody sHIgM22 and mouse IgM monoclonal antibody 94.03 bind to oligodendrocytes, induce calcium signals in cultured glial cells, and promote remyelination in mouse models of multiple sclerosis. In order to address the mechanisms employed by these antibodies to promote CNS repair, bivalent monomers, F(ab′)2 fragments, and monovalent forms of these antibodies were investigated to determine whether they exhibit the same remyelinating potential as the intact IgMs. The two antibodies displayed different structural requirements for retention of function. Antibody sHIgM22 remained functional even when reduced to a bivalent F(ab′)2 fragment, while disruption of the pentameric structure of antibody 94.03 destroyed its functional properties. Competition studies demonstrated that the two antibodies recognize different entities on the surface of glial cells. These results indicate that the constant region and pentameric structure of IgM is not always necessary for the stimulation of myelin repair, eliminating the requirement for IgM immune effector functions in this process. The ability of the antibodies to crosslink cell surface determinants on oligodendrocytes appears to be an essential aspect of the mechanism of cellular activation. The finding that two antibodies, which induce similar in vivo effects, bind to different structures, and have different cross‐linking requirements suggests that activation of glial cells involves the rearrangement of a complex membrane compartment.

Full Text

The Full Text of this article is available as a PDF (372.8 KB).

References

  • 1. Asakura K, Miller DJ, Murray K, Bansal R, Pfeiffer SE, Rodriguez M (1996) Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 43:273–281. [DOI] [PubMed] [Google Scholar]
  • 2. Asakura K, Miller DJ, Pease LR, Rodriguez M (1998) Targeting of IgMk antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci 18:7700–7708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Bar‐Dayan Y, Bonnin E, Bloch M, Schweitzer R, Ravid M, Kazatchkine MD, Kaveri SV (2000) Neutralization of disease associated autoantibodies by an immunoglobulin M‐ and immunoglobulin A‐enriched human intravenous immunoglobulin preparation. Scand J Immunol 51:408–414. [DOI] [PubMed] [Google Scholar]
  • 4. Beale D, Van Dort T. (1982) A comparison of the proteolytic fragmentation of immunoglobulin M from several different mammalian species. Comp Biochem Physiol 71 B:475–482. [DOI] [PubMed] [Google Scholar]
  • 5. Bieber AJ, Warrington A, Asakura K, Ciric B, Kaveri, SV , Pease LR, Rodriguez M (2002) Human antibodies accelerate the rate of remyelination following lysolechitininduced demyelination in mice. Glia 37:241–249. [DOI] [PubMed] [Google Scholar]
  • 6. Bieber AJ, Warrington A, Pease LR, Rodriguez M (2001) Humoral autoimmunity as a mediator of CNS repair. Trends Neurosci 24:S39–S44. [DOI] [PubMed] [Google Scholar]
  • 7. Chang A, Tourtellote WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165–173. [DOI] [PubMed] [Google Scholar]
  • 8. Ciric B, VanKeulen V, Rodriguez M, Kyle RA, Gertz MA, Pease LR (2001) Clonal evolution in Waldenstrom macroglobulinemia highlights role of B‐cell receptor. Blood 97:321–323. [DOI] [PubMed] [Google Scholar]
  • 9. Deller MC, Yvonne JE (2000) Cell surface receptors. Curr Opin Struct Biol 10:213–219. [DOI] [PubMed] [Google Scholar]
  • 10. Ehrestein MR, O'Keefe TL, Davies SL, Neuberger MS (1998) Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A 95:10089–10093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, Silver J, Hardy RR (1999) Positive selection of natural autoreactive B cells. Science 285:113–116. [DOI] [PubMed] [Google Scholar]
  • 12. Hunter SF, Rodriguez M (1997) Monoclonal remyelinationpromoting natural antibodies SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. J Neuro Sci 150:103–113. [DOI] [PubMed] [Google Scholar]
  • 13. Hurez V, Kazatchkine MD, Vassilev T, Ramanathan S, Pashov A, Basuyaur B, De Kozak Y, Bellon B, Kaveri SV (1997) Pooled normal human polyspecific IgM contains neutralizing anti‐idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood 90:4004–4013. [PubMed] [Google Scholar]
  • 14. Kuhlmann T, Bruck W (1999) Immunoglobulins induce increased myelin debris clearance by mouse macrophages. Neurosci Letters 275:191–194. [DOI] [PubMed] [Google Scholar]
  • 15. Lassman H, Bruck W, Lucchinetti C, Rodriguez M (1997) Remyelination in multiple sclerosis. Multiple Sclerosis 3:113–136. [DOI] [PubMed] [Google Scholar]
  • 16. Lin LC, Putnam FW (1978) Cold pepsin digestion: a novel method to produce the Fv fragment from human immunoglobulin M. Proc Natl Acad Sci U S A 75:2649–2653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Martin F, Kearney JF (2000) Selection in the mature B cell repertoire. Curr Top Microbiol Immunol 252:97–105. [DOI] [PubMed] [Google Scholar]
  • 18. McGavern DB, Murray PD, Rodriguez M (1999) Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. J Neurosci Res 58:492–504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Miller, DJ , Sanborn KS, Katzmann JA, Rodriguez M (1994) Monoclonal antibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14:6230–6238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Mitsunaga Y, Ciric B, VanKeulen V, Warrington AE, Mateo Paz Soldan M, Bieber AJ, Rodriguez M, Pease LR (2002) Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic‐progressive demyelinating disease. FASEB J express article 10.1096/fj.01‐0994fje. [DOI] [PubMed]
  • 21. Parkhouse RME (1975) Non‐covalent association of IgM subunits produced by reduction and alkylation. Immunol 27:1063–1071. [PMC free article] [PubMed] [Google Scholar]
  • 22. Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR (1999) Immunoglobulin M‐ enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 93:942–951. [PubMed] [Google Scholar]
  • 23. Rodriguez M, Leibowitz JL, Lampet PW (1983) Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis. Ann Neurol 13:426–433. [DOI] [PubMed] [Google Scholar]
  • 24. Rodriguez M, Lennon VA (1996) Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurol 46:538–545. [DOI] [PubMed] [Google Scholar]
  • 25. Rodriguez M, Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27:12–17. [DOI] [PubMed] [Google Scholar]
  • 26. Rudich SM, Winchester R, Mongini PK (1985) Human B cell activation. Evidence for diverse signals provided by various monoclonal anti‐IgM antibodies. J Exp Med 162:1236–1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Sakata N, Hamelmann E, Siadak AW, Terada N, Gerwins P, Aruffo A, Johnson GL, Gelfand EW (2000) Differential regulation of CD40‐mediated human B cell responses by antibodies directed against different CD40 epitopes. Cell Immunol 201:109–123. [DOI] [PubMed] [Google Scholar]
  • 28. Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Rodriguez M (2003) Remyelination‐promoting antibodies activate distinct Ca(2+) influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci 22:14–24. [DOI] [PubMed] [Google Scholar]
  • 29. Sommer I, Schachner M (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83:311–327. [DOI] [PubMed] [Google Scholar]
  • 30. Sorensen PS (2003) The role of intravenous immunoglobulin in the treatment of multiple sclerosis. J Neurol Sci 206:123–130. [DOI] [PubMed] [Google Scholar]
  • 31. Sorensen PS, Wanscher B, Jensen CV, Schreiber K, Blinkenberg M, Ravnborg M, Kirsmeier H, Larsen VA, Lee ML (1998) Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis. Neurol 50:1273–1281. [DOI] [PubMed] [Google Scholar]
  • 32. Vassilev T, Yamamoto M, Aissaoui A, Bonnin E, BerrihAknin S, Kazatchkine MD, Kaveri SV (1999) Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice. Eur J Immunol 29:2436–2442. [DOI] [PubMed] [Google Scholar]
  • 33. Villarroya M, Lopez MG, Cano‐Abad MF, Garcia AG (1999) Calcium signaling protocols In: Methods in molecular biology, Lambert DG (ed.), Volume 114, pp. 137–147, Humana Press, Totowa , New Jersey . [DOI] [PubMed] [Google Scholar]
  • 34. Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, Kaveri SV, Kyle RA, Pease LR, Rodriguez M (2000) Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A 97:6820–6825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Mitsunaga Y, Mateo Paz Soldan M, Rodriguez M (2001) Immunoglobulin‐mediated CNS repair. J Allergy Clin Immunol 108:4, S121–S125. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES